Home/Pipeline/Non-invasive Diaphragm Stimulation System

Non-invasive Diaphragm Stimulation System

Prevention/Treatment of Ventilator-Induced Diaphragm Dysfunction (VIDD) in ICU Patients

Pre-clinical / Early FeasibilityActive

Key Facts

Indication
Prevention/Treatment of Ventilator-Induced Diaphragm Dysfunction (VIDD) in ICU Patients
Phase
Pre-clinical / Early Feasibility
Status
Active
Company

About Stimit AG

Stimit AG is a private, pre-revenue medical device innovator targeting a critical unmet need in respiratory and critical care. The company's core technology is a non-invasive system for transcutaneous diaphragm stimulation, aimed at maintaining diaphragm muscle mass and function in sedated, mechanically ventilated ICU patients to reduce ventilator-induced diaphragm dysfunction (VIDD). By promoting a more natural, diaphragm-driven breath, Stimit's approach has the potential to shorten ventilation time, decrease ICU complications, and improve patient outcomes. The technology is currently in development, with no approved products on the market as of the provided information.

View full company profile